PAULINA GOSSMAN: Open Payments
NPI 1962180224 · HAMBURG, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 13 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $432 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $62 |
| Viatris Specialty LLC | 2 | $43 |
| Boston Scientific Corporation | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: YUPELRI, ZEPBOUND, MOUNJARO, WATCHMAN Access System, CAPLYTA, ELIQUIS, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across IA — which companies pay providers there.
